SINTX TECHNOLOGIES INC (SINT)
US8293926049 - Common Stock
SINT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 196 industry peers in the Health Care Equipment & Supplies industry. SINT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, SINT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SINT has reported negative net income.
SINT had a negative operating cash flow in the past year.
In the past 5 years SINT always reported negative net income.
SINT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
SINT has a worse Return On Assets (-53.90%) than 71.43% of its industry peers.
SINT's Return On Equity of -94.40% is on the low side compared to the rest of the industry. SINT is outperformed by 67.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.9% | ||
| ROE | -94.4% | ||
| ROIC | N/A |
ROA(3y)-67.04%
ROA(5y)-67.51%
ROE(3y)-145.96%
ROE(5y)-129.28%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 69.79%, SINT belongs to the top of the industry, outperforming 81.12% of the companies in the same industry.
In the last couple of years the Gross Margin of SINT has grown nicely.
The Profit Margin and Operating Margin are not available for SINT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y51.09%
GM growth 5Y11.89%
2. Health
2.1 Basic Checks
SINT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SINT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SINT has more shares outstanding
The debt/assets ratio for SINT has been reduced compared to a year ago.
2.2 Solvency
SINT has an Altman-Z score of -26.97. This is a bad value and indicates that SINT is not financially healthy and even has some risk of bankruptcy.
SINT has a worse Altman-Z score (-26.97) than 89.29% of its industry peers.
SINT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -26.97 |
ROIC/WACCN/A
WACC9.87%
2.3 Liquidity
SINT has a Current Ratio of 1.90. This is a normal value and indicates that SINT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.90, SINT is not doing good in the industry: 73.98% of the companies in the same industry are doing better.
SINT has a Quick Ratio of 1.60. This is a normal value and indicates that SINT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SINT (1.60) is worse than 67.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.6 |
3. Growth
3.1 Past
SINT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.65%, which is quite impressive.
SINT shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.64%.
The Revenue has been growing by 92.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)94.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q98.88%
Revenue 1Y (TTM)67.64%
Revenue growth 3Y64.51%
Revenue growth 5Y92.26%
Revenue growth Q2Q17.14%
3.2 Future
Based on estimates for the next years, SINT will show a very strong growth in Earnings Per Share. The EPS will grow by 26.93% on average per year.
Based on estimates for the next years, SINT will show a quite strong growth in Revenue. The Revenue will grow by 11.53% on average per year.
EPS Next Y33.36%
EPS Next 2Y26.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year46.24%
Revenue Next 2Y11.53%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
SINT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SINT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as SINT's earnings are expected to grow with 26.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.93%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SINT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SINTX TECHNOLOGIES INC
NASDAQ:SINT (4/19/2024, 12:25:10 PM)
0.0454
+0.01 (+13.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.32M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.9% | ||
| ROE | -94.4% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.79% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.6 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)94.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y33.36%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)67.64%
Revenue growth 3Y64.51%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y